Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 5/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8967164 | 0.89 | THRB (0.42) | TSHRCA1CA2THRB | |
| SCHEMBL4263378 | 0.81 | — | — | |
| SCHEMBL1017192 | 0.80 | ANPEP (0.39) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL8966564 | 0.80 | ADRB2 (0.39) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL7789709 | 0.79 | ADRB2 (0.43) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL1140477 | 0.78 | ADRB2 (0.38) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL8727179 | 0.75 | ADRB2 (0.45) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL50476 | 0.75 | ADRB2 (0.45) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL245354 | 0.75 | ADRB2 (0.45) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL20224725 | 0.75 | ADRB2 (0.45) | ADRB2ADRB1ADRB3TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5218138-A | Forming a complex with dialkylated borane and reducing the complex | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1993-06-08 | — | — | US | claimed |
| US-12582745-B2 | Adhesive composition for hard tissue repair | JIAXING JINGYIN BIOTECHNOLOGY CO., LTD (CN) | 2026-03-24 | — | — | US | disclosed |
| US-20240082457-A1 | HARD TISSUE REPAIR ADHESIVE COMPOSITION AND HARD TISSUE REPAIR KIT THEREOF | Jiaxing Jingyin Biotechnology Co., Ltd. (CN) | 2024-03-14 | — | — | US | disclosed |
| US-20240016973-A1 | ADHESIVE COMPOSITION FOR HARD TISSUE REPAIR | Jiaxing Jingyin Biotechnology Co., Ltd. (CN) | 2024-01-18 | — | — | US | disclosed |
| CN-112717196-B | Adhesive composition for repairing hard tissue | 嘉兴市京吟生物科技有限公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-113332486-B | Adhesive composition for hard tissue repair and kit for hard tissue repair | 嘉兴市京吟生物科技有限公司 | 2022-09-20 | — | — | CN | disclosed |
| WO-2022147912-A1 | HARD TISSUE REPAIR ADHESIVE COMPOSITION AND HARD TISSUE REPAIR KIT THEREOF | 嘉兴市京吟生物科技有限公司 | 2022-07-14 | — | — | WO | disclosed |
| WO-2022121131-A1 | ADHESIVE COMPOSITION FOR HARD TISSUE REPAIR | 嘉兴市京吟生物科技有限公司 | 2022-06-16 | — | — | WO | disclosed |
| CN-113332486-A | Adhesive composition for hard tissue repair and kit for hard tissue repair | 嘉兴市京吟生物科技有限公司 | 2021-09-03 | — | — | CN | disclosed |
| CN-112717196-A | Adhesive composition for repairing hard tissue | 嘉兴市京吟生物科技有限公司 | 2021-04-30 | — | — | CN | disclosed |
| EP-0519496-B1 | Thermosetting copolymers, silicon carbide-based fiber and processes for producing same | TONEN CORP (JP) | 1996-05-22 | — | — | EP | disclosed |
| EP-0404503-B1 | Boron-containing, silicon nitride-based ceramic shaped body production process | TONEN CORP (JP) | 1996-03-06 | — | — | EP | disclosed |
| EP-0389084-B1 | Process for producing a polyborosilazane | TONEN CORP (JP) | 1995-09-20 | — | — | EP | disclosed |
| US-5292830-A | Silane, silazane, boron block crosslinked copolymers | TONEN CORPORATION (JP) | 1994-03-08 | — | — | US | disclosed |
| US-5218138-A | Forming a complex with dialkylated borane and reducing the complex | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1993-06-08 | — | — | US | disclosed |
| EP-0519496-A1 | Thermosetting copolymers, silicon carbide-based fiber and processes for producing same | Tonen Corporation (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-5128286-A | BORON-CONTAINING, SILICON NITRIDE-BASED CERAMIC SHAPED BODY | TONEN CORPORATION (JP) | 1992-07-07 | — | — | US | disclosed |
| US-5030744-A | Polyborosilazane and process for producing same | TONEN CORPORATION (JP) | 1991-07-09 | — | — | US | disclosed |
| EP-0404503-A1 | Boron-containing, silicon nitride-based ceramic shaped body production process | Tonen Corporation (JP) | 1990-12-27 | — | — | EP | disclosed |
| EP-0389084-A2 | Process for producing a polyborosilazane | Tonen Corporation (JP) | 1990-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582745-B2 | Adhesive composition for hard tissue repair | PTK2, COL2A1, ILK | ADRB2 3450/4885ADRB1 3684/4885ADRB3 3188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.